The coordinated levels of ROS, p-GSK-3β (Ser9), p-p70S6K (Thr389), and CXCL8 from ovarian cancer may be used as new biomarkers for ovarian cancer development and prognosis. This evidence concerns the gene RPS6KB1 and ovarian carcinoma.